Navigation Links
World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
Date:11/21/2008

New evidence from large-scale studies points to a relationship between erectile dysfunction and prostate enlargement. Because of this, J. Francois Eid, M.D. has decided to expand his practice to increase the treatment of BPH in men. The focus of Dr. Eid's practice, Advanced Urological Care, has primarily been erectile dysfunction (ED). Dr. Eid will continue with ED treatments while building his BPH caseload.

New York, New York (PRWEB) November 21, 2008 -- Dr. J. Francois Eid has performed more internal penile implant surgeries than anyone in the world and has built a reputation for excellence in the treatment of erectile dysfunction (ED). New evidence from large-scale epidemiological studies supports the relationship between erectile dysfunction and lower urinary tract symptoms caused by benign prostate enlargement. Furthermore, studies show that the chemical nitric oxide (NO) plays an important role in normal erectile function and in the function of the prostate. Finally, animal studies reveal that obstruction of the bladder by the prostate causes erectile dysfunction. For these reasons, Dr. Eid is now expanding his practice to treat more patients with benign prostate hyperplasia (BPH). Though he has treated many men with BPH in the past, Dr. Eid would like to make BPH a central area of focus, along with erectile dysfunction.

Little known is the fact that BPH affects 40 percent of men in their 50s, 60 percent of
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. World-Renowned Physicians Converge on Methodist Dallas Medical Center for Largest Live Demonstration of Its Kind in Texas
2. World-Renowned Scientists to Lead Immunology Course
3. World-renowned bioengineers to record history of medical inventions
4. World-Renowned Therapist Joins The Center for Children and Families In Its Work With the Nations Poorest Families
5. Lifeclinic International Has Named John T. Kelly, M.D., Ph.D. Chief Medical Officer
6. Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss No Diet, No Stuff Method. Hates Diets, Loves to Have People Help Themselves
7. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
8. Whos Who Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets, Wont Accept Compensation From Anyone, Sending Complete Guide Free to All
9. Mary Anne McCaffree, M.D., Elected to AMA Board of Trustees
10. Andrew W. Gurman, M.D., Re-Elected to Vice Speaker, AMA House of Delegates
11. William A. Hazel, Jr., M.D., Re-Elected to AMA Board of Trustees

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
(Date:11/26/2009)..., The copper sequestering drug tetrathiomolybdate... the treatment of Wilson disease, a disease caused...cancers. That much is known. Very little, however,...r level. , A new study led by Northwestern Unive...lue: the three-dimensional structure of TM bound t...
(Date:11/26/2009)..., No more letters from th...or,personalized text messages from Santa , ...effort to increase operational efficiencies at the...ng to help keep children all over the globe inform... ,Elves in Santa’s research department have ...
(Date:11/26/2009)..., Benton Communications a...iness growth system for retailers struggling to ma... (PRWEB) November 26, 2009 -- Flu fears is the ty...es to the emergency room, according to Dr. David B...wly released business growth system – The R...
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBar...ion,slargestmedicalcliniconDec.9-10,whenKansasCity...suredpeople. ,, "Thisfreecliniceventhasthepoten...odaysinsteadofjustoneandbeheldonweekdaysinsteadofo...sCityFreeHealthClinicandpresidentoftheNationalAsso...
(Date:11/25/2009)...,, TORONTO,Nov.25/PRNewswire/-SentinelleMedi...ancedvisualizationsoftwarelaunchesasuiteofnewleadi...gingsoftwareplatformatthisyear,sRadiologicalSociet...-Dec.5,2009(Booth5800,HallA).Theapplicationslevera...sspecializedMRIimagingcoilsandsupportmultipleimagi...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...IHE, and BCBSA Target April 2009 Interoperability ...ng Project Demonstration , , WASHINGTON, Jan. 5 ...nounced today they are collaborating with the Cent...tions implementation. The organizations include C...
...ars to delay dangerous heart muscle expansion in m... ,Tests in mouse hearts show that sildenafil, the ...amage caused by high blood pressure, a new study s...s blood-pumping function from spiraling into heart...
...a., Jan. 5 Governor Edward G. Rendell expressed d...ministration -- now in their waning days -- would ...tient care and limit a woman,s access to medical t...that could have serious, detrimental impacts on pa...
...an. 5 Resolving to eat more fish, which contain,l... sage advice for most,consumers, especially for th...rch. The December 2008 Fats of Life and PUFA News...alian study with nearly 7,000 heart failure patien...
... Jan. 5 The Mobile Massage Team ( www.mobilemassa... massage services for corporate wellness programs,... eleven new team members to its therapist roster i...ge Team. "They reflect the continued growth of our...
...N.Y., Jan. 5 Misonix, Inc. (Nasdaq: MSON ), a d...device technology, which in Europe is used for the...health conditions, has entered into a definitive, ... interim agreement announced on November 7, 2008. ...
Other Medicine News:Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 2Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 3Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 4Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 5Health News:Viagra May Shield Heart From Blood Pressure Damage 2Health News:Gov. Rendell Expresses Disappointment with Bush Administration's Last-Minute Regulation Limiting Patient Care 2Health News:Gov. Rendell Expresses Disappointment with Bush Administration's Last-Minute Regulation Limiting Patient Care 3Health News:Eating More Fish a Wise New Year Resolution, Studies Show 2Health News:Mobile Massage Team Announces Eleven New Therapist Members in the Northeast U.S. Region 2Health News:Mobile Massage Team Announces Eleven New Therapist Members in the Northeast U.S. Region 3Health News:Misonix Announces New HIFU Distribution Agreement for Italy 2Health News:Misonix Announces New HIFU Distribution Agreement for Italy 3
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, IntranasalDrugDelivery-USMarketTre...4267/Intranasal-Drug-Delivery---US-Market-Trends--...rketiswitnessinganexpansionoftherapeuticapplicatio...gstothedeliveryofsystemictherapeuticdrugs.Thefutur...
(Date:11/25/2009)... MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCe...tafromtheCompany,sPROTECT-1(theProspectiveRandomiz...ficet-EN(TM)(CCX282-B)inpatientswithmoderate-to-se...afavorablesafetyandtolerabilityprofile.Thestudydem...fdiseaseseverityasdefinedasa70-pointdecreaseintheC...
(Date:11/24/2009)... IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endol...ivetreatmentsforaorticdisorders,announcedtodaythat...sin,thepatentinfringementlawsuitbroughtagainstitin...StatesDistrictCourtinIndianapolis,Indiana. ,, E...theUnitedStatesPatentandTrademarkOffice(USPTO)cond...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2UNC awarded 246 2 million renewal grant by NIH Rare Diseases Research Network 10336 1UNC awarded 246 2 million renewal grant by NIH Rare Diseases Research Network 10336 2 Tired Doctors More Prone to Errors 59371 1 Tired Doctors More Prone to Errors 59371 2 Tired Doctors More Prone to Errors 59371 3Discover Red Mangos New Seasonal Flavor 3A Pumpkin Spice 59366 1Discover Red Mangos New Seasonal Flavor 3A Pumpkin Spice 59366 2
...ENEVA, April 20, 2007 /PRNewswire/ -- Addex Pharma...n of a Phase IIa proof of,concept trial with its l...he study achieved its primary objective, the absen...al significance, and,also showed trends towards im...igraine pain at other time points. ADX10059 has,al...
...ATTLE--(BUSINESS WIRE)--Apr 19, 2007 - Gilead Scie...results of its Phase III,AIR-CF2 study evaluating ... patients with cystic fibrosis (CF) who have,pulmo...e study, a,28-day treatment course of aztreonam ly...nhaled or intravenous (IV) antibiotics versus,plac...
Other Medicine Technology:Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 2Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 3Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7
Atria 3100 ECG
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: